Advertisement
Canada markets close in 5 hours 54 minutes

  • S&P/TSX

    21,947.75
    +62.37 (+0.28%)
     

  • S&P 500

    5,094.11
    +45.69 (+0.91%)
     

  • DOW

    38,233.61
    +147.81 (+0.39%)
     

  • CAD/USD

    0.7317
    -0.0006 (-0.08%)
     

  • CRUDE OIL

    83.96
    +0.39 (+0.47%)
     

  • Bitcoin CAD

    87,988.39
    +1,329.27 (+1.53%)
     

  • CMC Crypto 200

    1,337.18
    -59.35 (-4.25%)
     

  • GOLD FUTURES

    2,351.90
    +9.40 (+0.40%)
     

  • RUSSELL 2000

    1,997.15
    +16.03 (+0.81%)
     

  • 10-Yr Bond

    4.6530
    -0.0530 (-1.13%)
     

  • NASDAQ

    15,866.44
    +254.68 (+1.63%)
     

  • VOLATILITY

    15.25
    -0.12 (-0.78%)
     

  • FTSE

    8,131.96
    +53.10 (+0.66%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • CAD/EUR

    0.6832
    +0.0011 (+0.16%)
     
MARKETS LIVE BLOG:

STOCKS RISE, LED BY STELLAR ALPHABET, MICROSOFT EARNINGS

Results from 'Magnificent Seven' duo show cloud revenue boosted by strong AI demand

CYDY ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of May 17, 2021 in the Class Action Filed on Behalf of CytoDyn Inc. Limited Shareholders

Newsfile Corp.
·2 min read

New York, New York--(Newsfile Corp. - April 14, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of CytoDyn Inc. (OTCQB: CYDY) alleging that the Company violated federal securities laws.

Class Period: March 27, 2020 and March 9, 2021
Lead Plaintiff Deadline: May 17, 2021

Learn more about your recoverable losses in CYDY:
http://www.kleinstocklaw.com/pslra-1/cytodyn-inc-loss-submission-form?id=14690&from=5

The filed complaint alleges that CytoDyn Inc. made materially false and/or misleading statements and/or failed to disclose that: CytoDyn securities were actively traded over the counter (OTC) in the United States. While the exact number of Class members is unknown to Plaintiff at this time and can be ascertained only through appropriate discovery, Plaintiff believes that there are hundreds or thousands of members in the proposed Class. Record owners and other members of the Class may be identified from records maintained by CytoDyn or its transfer agent and/or OTC Markets and may be notified of the pendency of this action by mail, using the form of notice similar to that customarily used in securities class actions.

ADVERTISEMENT

Shareholders have until May 17, 2021 to petition the court for lead plaintiff status. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

For additional information about the CYDY lawsuit, please contact J. Klein, Esq. by telephone at 212-616-4899 or click the link above.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/80409